We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+20.05%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.8B
AUM Growth
+$81.7M
Cap. Flow
+$42.6M
Cap. Flow %
2.36%
Top 10 Hldgs %
77.63%
Holding
52
New
1
Increased
3
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$62.6M
2
GTLB icon
GitLab
GTLB
+$28.1M
3
MOND
Mondee Holdings, Inc. Class A Common Stock
MOND
+$205K
4
NVTA
Invitae Corporation
NVTA
+$38.7K

Top Sells

Rank Stock Value
1
LYFT icon
Lyft
LYFT
+$18.8M
2
DUOL icon
Duolingo
DUOL
+$18.5M
3
NEWR
New Relic, Inc.
NEWR
+$5.14M
4
AMPL icon
Amplitude
AMPL
+$2.29M
5
FULC icon
Fulcrum Therapeutics
FULC
+$2.16M

Sector Composition

Rank Sector Weight
1 Healthcare 47.65%
2 Technology 40.29%
3 Industrials 8.37%
4 Financials 2.67%
5 Consumer Staples 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBTX
26
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$4.94M 0.27%
1,636,258
– –
BRNS
27
Barinthus Biotherapeutics
BRNS
$22.8M
$3.39M 0.19%
1,513,644
– –
FHTX icon
28
Foghorn Therapeutics
FHTX
$266M
$3.11M 0.17%
500,901
– –
DNTH icon
29
Dianthus Therapeutics
DNTH
$5.84B
$2.64M 0.15%
208,696
– –
TNYA icon
30
Tenaya Therapeutics
TNYA
$161M
$2.61M 0.14%
915,705
– –
VERA icon
31
Vera Therapeutics
VERA
$2.3B
$2.34M 0.13%
301,580
– –
RANI icon
32
Rani Therapeutics
RANI
$87M
$2.31M 0.13%
448,492
-61,636
-12% -$371K
TCRX icon
33
TScan Therapeutics
TCRX
$48.6M
$2.26M 0.13%
1,077,080
– –
KRON
34
DELISTED
Kronos Bio
KRON
$2.1M 0.12%
1,438,232
– –
EXAS
35
DELISTED
Exact Sciences
EXAS
$1.57M 0.09%
23,205
– –
HYPR icon
36
Hyperfine
HYPR
$92.9M
$1.29M 0.07%
898,720
– –
SPRO icon
37
Spero Therapeutics
SPRO
$67.7M
$1.29M 0.07%
889,979
– –
AUTL
38
Autolus Therapeutics
AUTL
$397M
$1.28M 0.07%
698,262
– –
ALEC icon
39
Alector
ALEC
$168M
$1.09M 0.06%
175,866
– –
SNCE
40
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$898K 0.05%
160,363
– –
TSHA icon
41
Taysha Gene Therapies
TSHA
$1.68B
$513K 0.03%
640,882
– –
OPRT icon
42
Oportun Financial
OPRT
$255M
$366K 0.02%
94,788
– –
NVTA
43
DELISTED
Invitae Corporation
NVTA
$318K 0.02%
235,606
+19,641
+9% +$38.7K
QNCX icon
44
Quince Therapeutics
QNCX
$22.9M
$295K 0.02%
946
– –
MOND
45
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$206K 0.01%
+18,420
New +$205K
EVLO
46
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$191K 0.01%
53,025
– –
RGEN icon
47
Repligen
RGEN
$7.96B
$64.5K ﹤0.01%
383
– –
HLTH
48
DELISTED
Cue Health Inc. Common Stock
HLTH
$49.1K ﹤0.01%
27,000
– –
FULC icon
49
Fulcrum Therapeutics
FULC
$273M
$40.6K ﹤0.01%
14,262
-241,190
-94% -$2.16M
AMPL icon
50
Amplitude
AMPL
$1.18B
– –
-189,447
Closed -$2.29M
1
2
3

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q1 2023 Portfolio in Review

As of Q1 2023, Alphabet Inc held 52 positions worth $1.8B, up 4.7% from $1.72B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Alphabet Inc's Q1 2023 filing shows 1 new, 3 increased, 4 reduced and 3 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 18,420 shares worth $206K. The largest sale was Lyft, an estimated $18.8M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

  • Alphabet Inc's largest Q1 2023 buy was Mondee Holdings, Inc. Class A Common Stock: 18,420 shares worth $206K.
  • Alphabet Inc added most to CrowdStrike in Q1 2023, an estimated $62.6M increase.
  • Alphabet Inc's biggest Q1 2023 reduction was Lyft, cutting an estimated $18.8M.
  • Alphabet Inc fully exited New Relic, Inc. in Q1 2023, selling an estimated $5.14M.
  • Alphabet Inc's ten largest holdings make up 78% of its $1.8B portfolio in Q1 2023.
  • Alphabet Inc opened 1 new position and closed 3 in Q1 2023.
  • Alphabet Inc's portfolio value rose 4.7% quarter-over-quarter to $1.8B.

Based on Alphabet Inc's 13F filing for Q1 2023, filed 11 May 2023.